About Us
STCube is dedicated to developing precision-driven immunotherapies,
bringing new hope to more cancer patients.
Leadership
  • Home
  • About Us
  • Leadership
Introduction of Key Executives
Chief Executive Officer (CEO)
Hyunjin Jung
  • Graduated from Seoul National University College of Medicine
  • Completed doctoral coursework at Seoul National University College of Medicine
  • Full-time resident, Department of Clinical Pathology, Seoul National University Hospital
  • Founder and CEO, Innocell
  • CEO, Biomedical Holdings, Inc. (Current)
  • CEO, STCube & Company, Inc. (Current)
Chief Scientific Officer (CSO)
Stephen Sunghan Yoo
  • BS, Department of Biology, Yonsei University
  • PhD, Biochemistry/Biophysics, Texas A&M University
  • Postdoctoral Fellow, Department of Biochemistry, Colorado State University
  • Fellow/Lecturer, Molecular Medicine and Genetics Institute, University of Georgia Medical School
  • Research Professor, Department of Radiology, Georgetown University
  • Director, Radiation Research Program, National Cancer Institute(NCI)
  • Department Head, Department of Radiation Combination Therapy, National Cancer Institute(NCI)
  • Current CEO, STCube Pharmaceuticals, Inc.